What is NDC 0002-1200?

0002-1200 is the product NDC for Amyvid (florbetapir f 18), Florbetapir f-18 51 mCi/mL injection, solution, listed with the FDA by Eli Lilly and Company. It has 2 package NDCs, shown above in 10- and 11-digit form.

Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Amyvid?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Amyvid NDC 0002-1200 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0002-1200Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00002-1200Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0002-1200-48	00002120048	1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-48) / 100 mL in 1 VIAL, MULTI-DOSEMarketed from May 22, 2023
0002-1200-50	00002120050	1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-50) / 50 mL in 1 VIAL, MULTI-DOSEMarketed from Jun 1, 2012

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amyvid
Generic name (nonproprietary): florbetapir f 18
Active ingredients: Florbetapir f-18 — 51 mCi/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Eli Lilly and CompanyNDC labeler code 0002
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 202008
Marketing start: Jun 1, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Positron Emitting Activity (Mechanism)
Identifiers: Product ID 0002-1200_63e1d0b5-c634-4699-91b2-643a6e765139SPL ID 63e1d0b5-c634-4699-91b2-643a6e765139SPL set ID bb5a5043-0f51-11df-8a39-0800200c9a66UNII 6W15Z5R0RU
Pharmacologic class: Radioactive Diagnostic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400002120048 followed by a unit qualifier and the quantity

Package 00002-1200-48. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025.

Indications (excerpt from the label)

AMYVID is indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information of the therapeutic products AMYVID is a radioactive diagnostic drug indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline Selection of patients who are indicated for am…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0002-1200

What is NDC 0002-1200?: 0002-1200 is the product NDC for Amyvid (florbetapir f 18), Florbetapir f-18 51 mCi/mL injection, solution, listed with the FDA by Eli Lilly and Company. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Amyvid (Florbetapir F 18).
What is the active ingredient?: Florbetapir f-18.
Who is the labeler?: Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Amyvid?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Amyvid (Florbetapir f 18) NDC 0002-1200